Status:
UNKNOWN
The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic Syndrome
Lead Sponsor:
National Defense Medical Center, Taiwan
Conditions:
Hyperuricemia
Healthy
Eligibility:
All Genders
20-65 years
Brief Summary
Hyperuricemia is associated with the prevalence of metabolic syndrome and cardiovascular risks in diverse of the population. Whether the dose-response effects on the prevalence of metabolic syndrome a...
Detailed Description
Apparently healthy individuals with an estimated screening number of approximately twenty-thousand individuals undergo an annual health exam in the investigators' hospital. The routine exam includes m...
Eligibility Criteria
Inclusion
- Individuals with ages of 20-65 years underwent the annual health exam at the investigators' hospital.
Exclusion
- The individual had no data to define metabolic syndrome, including waist circumference, office blood pressure, serum uric acid, triglyceride, high-density lipoprotein cholesterol, fasting glucose.
Key Trial Info
Start Date :
March 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
18000 Patients enrolled
Trial Details
Trial ID
NCT03473951
Start Date
March 26 2018
End Date
December 1 2020
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tri-service General Hospital, songshan branch
Taipei, Songshan Dist., Taiwan, 105